The prevalence of type 2 diabetes complications and their related factors in Semnan, Iran: a cross-sectional study

authors:

avatar Sayed Saeed Kassaeian ORCID , avatar navid danai , avatar Sadr Manouchehri Shahryar , avatar Mohammad Hossein Taherian ORCID , avatar Masoumeh Ebrahimi Tavani , avatar Ali Heidari Roochi , avatar Farid Gharibi , *

Koomesh: Vol.25, issue 3; 394-405
published online: June 02, 2023
article type: Research Article
received: April 02, 2023
accepted: June 02, 2023

how to cite: Kassaeian S S, danai N, Shahryar S M, Taherian M H, Ebrahimi Tavani M, et al. The prevalence of type 2 diabetes complications and their related factors in Semnan, Iran: a cross-sectional study. koomesh. 2023;25(3):e152838. 

Abstract

Introduction: Type 2 diabetes is a chronic disease and one of the major public health problems in societies due to its prevalence and complications. This study aims to assess the prevalence of type 2 diabetes complications and their related factors. Materials and Methods: This cross-sectional study included 400 diabetic patients (51% males vs. 49% females) in Semnan, Iran in 2023. The study tool was a researcher-made questionnaire whose content validity was confirmed by experts (CVR=0.90 and CVI=0.87). The descriptive results were calculated and reported as frequency (percentage) for qualitative variables and mean (standard deviation) for quantitative ones. Also, due to the qualitative nature of the variables, the statistical relationship between demographic and background variables with the prevalence of disease complications was evaluated using the chi-square test. Results: The mean age of participants was 51.93 years. According to the results, 19% of patients experienced type 2 diabetes complications, so that 8.5% had neuropathy (95% CI: ±2.73), 8% had retinopathy (95% CI: ±2.65), and 2.75% had nephropathy (95% CI: ±1.60). Among the demographic and background variables, the following items were significantly associated with the prevalence and severity of the complications: education level, employment status, nativity, urban or rural residency, type of basic health insurance, the time elapsed since diagnosis of the disease, the time interval between diagnosis of the disease and commencement of care, disease control status, and place of receiving care (P<0.05). Conclusion: The findings of the study indicated that the prevalence of type 2 diabetes complications was at an acceptable level compared to the national and international statistics. Moreover, in addition to factors such as the patients’ access to appropriate diagnostic and treatment facilities and improving self-care among patients, some geographical, occupational, and financial factors play a role in the prevalence of type 2 diabetes complications

References

  • 1.

    Forouzanfar MH, Sepanlou SG, Shahraz S, Dicker D, Naghavi P, Pourmalek F. Evaluating causes of death and morbidity in Iran, global burden of diseases, injuries, and risk factors study 2010. Arch Iran Med 2014;17: 304-320.

  • 2.

    Andersson E, Persson S, Halln N, Ericsson , Thielke D, Lindgren P, et al. Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden. Diabetologia 2020; 63: 2582-2594.

  • 3.

    Khamseh ME, Abdi H, Malek M, Shafiee G, Khodakarim S. Relationship between patients' perception of the importance of diabetes and metabolic control and pursuing chronic complications of disease. Koomesh 2011; 12: 334-341. (Persian).

  • 4.

    Belsti Y, Akalu Y, Animut Y. Attitude, practice and its associated factors towards Diabetes complications among type 2 diabetic patients at Addis Zemen District hospital, Northwest Ethiopia. BMC Public Health 2020; 20: 1-10.

  • 5.

    Abebe N, Kebede T, Addise D. Diabetes in Ethiopia 2000-2016 - prevalence and related acute and chronic complications; a systematic review. Afr J Diabet Med 2017; 25: 7-12.

  • 6.

    Oraii A, Shafiee A, Jalali A, Alaeddini F, Saadat S, Masoudkabir F, et al. Prevalence, awareness, treatment, and control of type 2 diabetes mellitus among the adult residents of tehran: Tehran Cohort Study. BMC Endocr Disord 2022; 22: 1-15.

  • 7.

    Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87: 4-14.

  • 8.

    Yoo H, Choo E, Lee S. Study of hospitalization and mortality in Korean diabetic patients using the diabetes complications severity index. BMC Endocr Disord 2020; 20: 1-10.

  • 9.

    Khamseh ME, Sepanlou SG, Hashemi-Madani N, Joukar F, Mehrparvar AH, Faramarzi E, et al. Nationwide prevalence of diabetes and prediabetes and associated risk factors among Iranian adults: analysis of ata from PERSIAN Cohort Study. Diabetes Ther 2021; 12: 2921-2938.

  • 10.

    Javanbakht M, Mashayekhi A, Baradaran HR, Haghdoost A, Afshin A. Projection of diabetes population size and associated economic burden through 2030 in Iran: evidence from microsimulation Markov model and Bayesian metaanalysis. PLoS One 2015; 10: e0132505.

  • 11.

    ukasiewicz A, Cicho E, Kostecka B, Kiejna A, Jodko-Modliska A, Obrbski M, et al. Association of higher rates of type 2 diabetes (T2DM) complications with psychological and demographic variables: results of a cross-sectional study. Diabetes Metab Syndr Obes 2022; 15: 3303-3317.

  • 12.

    Abdullah Ahmed S, Badi S, Tahir H, Mohamed HA, Omer Almobarak A. Knowledge and practice of diabetic foot care in Sudan: A cross sectional survey. Diabetes Metab Syndr 2019; 13: 2413-2435.

  • 13.

    Venkataraman K, Kannan AT, Mohan V. Challenges in diabetes management with particular reference to India. Int J Diabetes Dev Count 2009; 29: 103-109.

  • 14.

    Ohinmaa A, Jacobs P, Simpson S, Johnson JA. The projection of prevalence and cost of diabetes in Canada: 2000 to 2016. Can J Diabetes 2004; 28: 1-8.

  • 15.

    Olfatifar M, Karami M, Shokri P, Hosseini SM. Related and complications chronic of prevalence the to referred patients in diabetes of factors risk province Hamedan of center diabetes. Facul Midwifery Nurs Hamadan J Sci 2016; 25: 69-74. (Persian).##https://doi.org/10.21859/nmj-25029.

  • 16.

    Imani A, Gharibi F, Khezri A, Joudyian N, Dalal K. Economic costs incurred by the patients with multiple sclerosis at different levels of the disease: a cross-sectional study in Northwest Iran. BMC Neurol 2020; 20: 1-10.

  • 17.

    Mutyambizi C, Pavlova M, Hongoro C, Booysen F, Groot W. Incidence, socio-economic inequalities and determinants of catastrophic health expenditure and impoverishment for diabetes care in South Africa: a study at two public hospitals in Tshwane. Int J Equity Health 2019; 18: 1-15.

  • 18.

    Sheleme T, Mamo G, T M, Sahilu T. Prevalence, patterns and predictors of chronic complications of diabetes mellitus at a large referral hospital in Ethiopia: a prospective observational study. Diabetes Metab Syndr Obes 2020; 13: 4909-4918.

  • 19.

    Ageely H. Long-term diabetes-related severe complications among individuals with T2DM in Jazan, Saudi Arabia. J Acute Dis 2019; 8: 72-77.##https://doi.org/10.4103/2221-6189.254430.

  • 20.

    Liu Z, Fu C, Wang W, Xu B. Prevalence of chronic complications of type 2 diabetes mellitus in outpatients - a cross-sectional hospital based survey in urban China. Health Qual Life Outcomes 2010; 8: 1477-1525.

  • 21.

    Goday A. Epidemiology of diabetes and its non-coronary complications. Rev Esp Cardiol 2002; 55: 657-670.

  • 22.

    Arambewela MH, Somasundaram NP, Jayasekara H. Prevalence of chronic complications, their risk factors, and the cardiovascular risk factors among patients with type 2 diabetes attending the diabetic clinic at a tertiary care hospital in Sri Lanka. J Diabetes Res 2018; 23: 4504287.

  • 23.

    Shera A, Jawad F, Maqsood A, Jamal S, Azfar M, Ahmed U. Prevalence of chronic complications and associated factors in type 2 diabetes. J Pak Med Assoc 2004; 54: 54-59.

  • 24.

    Funakoshi M, Azami Y, Matsumoto H, Ikota A, Ito K, Okimoto H. Socioeconomic status and type 2 diabetes complications among young adult patients in Japan. PLoS One 2017; 12: e0176087.

  • 25.

    Martins RB, Ordaz-Briseo SA, Flores-Hernndez S, Gonalves Bs AJ, Baptista-Rosas RC, Mercado-Sesma AR. Comparison of prevalence of diabetes complications in Brazilian and Mexican adults: a cross-sectional study. BMC Endocr Disord 2021; 21: 1-9.

  • 26.

    Bs AJG, Ianiski VB, Camacho NCA, Martins RB, Rigo IR, Grigol MC, et al. Differences in the socioeconomic and health profiles of older adults in rural and urban environments: 2013 national health survey. Geriatr Gerontol Aging 2018; 12: 148-153.##https://doi.org/10.5327/Z2447-211520181800027.

  • 27.

    Price AJ, Crampin AC, Amberbir A, Kayuni-Chihana N, Musicha C, Tafatatha T, et al. Prevalence of obesity, hypertension, and diabetes, and cascade of care in sub-Saharan Africa: a cross-sectional, population-based study in rural and urban Malawi. Lancet Diabetes Endocr 2018; 6: 208-222.

  • 28.

    Schiborn C, Schulze MB. Precision prognostics for the development of complications in diabetes. Diabetologia 2022; 65: 1867-1882.

  • 29.

    Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocr 2018; 14: 88-98.

  • 30.

    LaelMonfared E, Tehrani H, Teiho Z, Jafari A. The study of eye care behaviors in patients with type 2 diabetes. J Diabetes Metab Disord 2020; 19: 257263.

  • 31.

    Doustmohamadian S, Kia NS, Fatahi S. Associated factors of poor glycemic control in Iranian diabetic patients. Koomesh 2021; 23: 372-378. (Persian).##https://doi.org/10.52547/koomesh.23.3.372.